Vonavir Tablet (Emtricitabine/Tenofovir/Efavirenz)
| Active Ingredient | Emtricitabine/Tenofovir/Efavirenz |
|---|---|
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Indication: | HIV infection |
| Strength | 300mg/200mg/600mg |
| Packaging | 30 Tablets in bottle |
| Delivery Time | 6 To 15 days |
Vonavir Tablet is a fixed-dose combination of three powerful antiretroviral drugs: Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz. It is used for the treatment of HIV-1 infection in adults and adolescents. This once-daily single-tablet regimen is part of the highly active antiretroviral therapy (HAART) protocol and works by inhibiting the replication of HIV in the body, improving immune function, and delaying the progression to AIDS.
Key Ingredients:
Emtricitabine – a nucleoside reverse transcriptase inhibitor (NRTI)
Tenofovir – a nucleotide reverse transcriptase inhibitor (NtRTI)
Efavirenz – a non-nucleoside reverse transcriptase inhibitor (NNRTI)
Uses of Vonavir:
First-line treatment of HIV-1 infection
Reduces viral load and increases CD4 cell counts
Helps in improving long-term immune health
Dosage & Administration:
Typically taken once daily on an empty stomach, preferably at bedtime to reduce side effects.
Strict adherence to daily dosage is essential to prevent resistance.
Only use under the supervision of a qualified healthcare provider.








There are no reviews yet.